Look out Gluten, Glutagest® has arrived in Canada
15 Jun, 2016, 08:00 ET
TORONTO, June 15, 2016 /CNW/ - Exzell Pharma Inc has announced the launch of Glutagest®, the probiotic you take with a meal that contains, or is suspected to contain, gluten.
Glutagest® is a patented, non-refrigerated probiotic that has been approved by Health Canada as a Natural Health Product that helps support intestinal/gastrointestinal health. Adults (18 years and over) take 1 to 2 capsules 5 minutes prior to Gluten containing meals and 1 to 2 capsules following the meal.
About Gluten Sensitivity and the Gluten-Free Diet
Gluten Sensitivity, which is different from Celiac Disease as it does not cause damage to the small intestine, could affect 6 % of the population.i,ii The Gluten-free product market has grown significantly and it is estimated that almost one third of Canadians buy gluten-free products.ii
About Cross Contamination and Hidden Gluten
Though the number of gluten free food options available on the market has increased, the possibility of cross-contamination of foods, and consuming hidden gluten remains. Gluten-free foods can become contaminated with trace gluten when they come into contact with gluten containing foods, or a surface or utensil that was used with a gluten containing food.
Gluten-free pizza dough that is rolled on the same surface as regular dough, or gluten-free bread toasted in the same toaster as regular bread can contaminate gluten-free foods with trace amounts of gluten. Consumers can unintentionally ingest gluten by consuming foods that are not traditionally considered gluten-contain foods, such as some salad dressings, condiments, candies, and luncheons meats.
Glutagest® contains the patented Bifidobacterium longum ES1 strain probiotic. The capsules are vegetable cellulose and do not need to be refrigerated. Glutagest® is Dairy Free, Non-GMO, and does NOT contain: meat, egg protein, fish, nuts, gluten, soy, corn nor shellfish.
About Exzell Pharma Inc.
Exzell Pharma Inc in a privately held, Markham, Ontario company that focuses on marketing products that treat gastrointestinal disorders and treatments with less gastrointestinal side effects for common disorders. Exzell Pharma currently markets Glutagest® in the U.S. (www.glutagest.com) and Canada (www.glutagest.ca)
i) BMC Medicine 2012. Retrieved June 10, 2016. Available at http:biomedcentral.com/1741-7015/10/13
ii) Agriculture and Agri-Food Canada, Government of Canada. 2014. Retrieved June 10, 2016 Available at http://www.agr.gc.ca/eng/industry-markets-and-trade/statistics-and-market-information/by-product-sector/processed-food-and-beverages/reports-and-resources-food-processing-innovation-and-regulations
SOURCE Exzell Pharma
Image with caption: "Glutagest 30 Capsule Package Canada (CNW Group/Exzell Pharma)". Image available at: http://photos.newswire.ca/images/download/20160615_C6035_PHOTO_EN_713099.jpg
For further information: Kyla Czerwinski, Phone: (905) 475-1234, E-mail: [email protected], www.exzell.com, www.glutagest.ca
Share this article